{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:42:16Z","timestamp":1792644136216,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005701","name":"\u00c5hl\u00e9n-stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009673","name":"Gun och Bertil Stohnes Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/ SG \/11\/2024-01-02095"],"award-info":[{"award-number":["EMDR\/ SG \/11\/2024-01-02095"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018850","name":"Gunvor och Josef An\u00e9rs Siftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021594","name":"Demensfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018007","name":"Ulla-Carin Lindquists stiftelse f\u00f6r ALS-forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119353","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:35:38Z","timestamp":1790231738000},"page":"119353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rational design, synthesis, and biological evaluation of indole\u2013piperazine based \u03b1-ketoamide derivatives as dual A\u03b2 and tau aggregation modulators for Alzheimer's disease"],"prefix":"10.1016","volume":"320","author":[{"given":"Bhanuranjan","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag TK.","family":"Baidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Chouhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikesh Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banita","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-6258","authenticated-orcid":false,"given":"Taher","family":"Darreh-Shori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5543-5963","authenticated-orcid":false,"given":"Gefei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7021-6996","authenticated-orcid":false,"given":"Rajnish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119353_bib1","first-page":"371","volume":"vol. 8","author":"Porsteinsson","year":"2021"},{"key":"10.1016\/j.ejmech.2026.119353_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/B978-0-443-13205-6.00009-1","article-title":"Symptoms and conventional treatments of alzheimer's disease","author":"Chorawala","year":"2024","journal-title":"Alzheimer's Disease and Advanced Drug Delivery Strategies"},{"key":"10.1016\/j.ejmech.2026.119353_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of alzheimer's disease and other dementias, 1990\u20132019","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2026.119353_bib4","first-page":"644","volume":"vol. 54","author":"G\u00fcner","year":"2024"},{"key":"10.1016\/j.ejmech.2026.119353_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-230827","article-title":"Assessing the global, regional, and national impact of high body mass index on Alzheimer's disease and other dementias between 1990 and 2019","volume":"97","author":"Hao","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119353_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"Alzheimer's disease facts and figures","volume":"15","author":"Association","year":"2019","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ejmech.2026.119353_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"Alzheimer's disease facts and figures","volume":"11","author":"Association","year":"2015","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejmech.2026.119353_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-025-08186-8","article-title":"Amyloid-\u03b2 and tau in Alzheimer's disease: pathogenesis, mechanisms, and interplay","volume":"17","author":"Abdulkhaliq","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119353_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3390\/biom16040595","article-title":"Tau and \u03b2-Amyloid relevant pathology as a central therapeutic target in alzheimer's disease","volume":"16","author":"Stru\u017cy\u0144ska","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.119353_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2025.102750","article-title":"Understanding the complex interplay between tau, amyloid and the network in the spatiotemporal progression of Alzheimer's disease","volume":"249","author":"Raj","year":"2025","journal-title":"Progress in neurobiology"},{"key":"10.1016\/j.ejmech.2026.119353_bib11","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1007\/s12035-024-04543-4","article-title":"Morphological and molecular profiling of amyloid-\u03b2 species in Alzheimer's pathogenesis","volume":"62","author":"Almeida","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2026.119353_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12035-025-05602-0","article-title":"Toward a unified framework in molecular neurobiology of Alzheimer's disease: revisiting the pathophysiological hypotheses","volume":"63","author":"Hein","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2026.119353_bib13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution","volume":"81","author":"Stefani","year":"2003","journal-title":"Journal of molecular medicine"},{"key":"10.1016\/j.ejmech.2026.119353_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00018-022-04166-9","article-title":"Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies","volume":"79","author":"Cascella","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2026.119353_bib15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/17568919.2026.2636501","article-title":"Medicinal chemistry approaches for dual inhibition of amyloid-\u03b2 and tau aggregation in Alzheimer's disease","volume":"18","author":"Jangra","year":"2026","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119353_bib16","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1021\/acschemneuro.1c00235","article-title":"Dual inhibitors of amyloid-\u03b2 and tau aggregation with amyloid-\u03b2 disaggregating properties: extended in cellulo, in silico, and kinetic studies of multifunctional anti-alzheimer\u2019s agents","volume":"12","author":"Pasieka","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119353_bib17","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1039\/D5MD00963D","article-title":"PROTAC-mediated multi-target protein degradation in alzheimer's disease: mechanistic insights, therapeutic applications, and translational challenges","volume":"17","author":"Li","year":"2026","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119353_bib18","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.7150\/ijbs.131465","article-title":"A novel PROTAC confers a dual benefit against amyloid and tau pathology in alzheimer's Disease via DAPK1 degradation","volume":"22","author":"Li","year":"2026","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejmech.2026.119353_bib19","series-title":"The Neurodegeneration Revolution","first-page":"117","article-title":"Current pharmacological treatments for neurodegenerative diseases","author":"Shukla","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119353_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1570159X20666220411083922","article-title":"Strategies for treatment of disease-associated dementia beyond Alzheimer's disease: an update","volume":"21","author":"Khan","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2026.119353_bib21","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3390\/molecules29215131","article-title":"Recent advances in therapeutics for the treatment of Alzheimer's disease","volume":"29","author":"Thawabteh","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119353_bib22","doi-asserted-by":"crossref","DOI":"10.1590\/1980-5764-dn-2024-0204","article-title":"Advancements in the treatment of alzheimer's disease: a comprehensive review","volume":"19","author":"Rajanna","year":"2025","journal-title":"Dementia & Neuropsychologia"},{"key":"10.1016\/j.ejmech.2026.119353_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134782","article-title":"Synthesis, single crystal X-ray, DFT, spectroscopic, molecular docking studies and in vitro biological evaluation of compound N-benzyl-4-(4-chlorophenyl)-2-oxobutanamide","volume":"1276","author":"Das","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119353_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107373","article-title":"Synthesis and biological evaluation of halogen-substituted novel \u03b1-Ketoamides as potential protein aggregation modulators in Alzheimer's disease","volume":"147","author":"Das","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119353_bib25","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/adsc.201900222","article-title":"Transition\u2010metal\u2010free reduction of \u03b1\u2010Keto thioesters with hydrosilanes at room temperature: divergent synthesis through reagent\u2010controlled chemoselectivities","volume":"361","author":"Maity","year":"2019","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2026.119353_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116614","article-title":"Structural modification aimed for improving solubility of lead compounds in early phase drug discovery","volume":"56","author":"Das","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119353_bib27","doi-asserted-by":"crossref","first-page":"40769","DOI":"10.1021\/acsomega.5c06171","article-title":"Advanced drug delivery strategies to overcome solubility and permeability challenges: driving biopharmaceutical advancements toward commercial success","volume":"10","author":"Hashmi","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119353_bib28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1517\/17425247.2013.762354","article-title":"Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB","volume":"10","author":"Nagpal","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejmech.2026.119353_bib29","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119353_bib30","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.3390\/cells10123521","article-title":"Cannabidiol inhibits tau aggregation in vitro","volume":"10","author":"Alali","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119353_bib31","article-title":"In vitro assay for studying the aggregation of tau protein and drug screening","volume":"58570","author":"Crespo","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejmech.2026.119353_bib32","first-page":"21","article-title":"Enhancing drug solubility and bioavailability through cyclodextrin inclusion complexes: an integrative molecular meta-modeling approach","volume":"1","author":"Shahiya","year":"2026","journal-title":"J. Comput. Biophys. Chem"},{"key":"10.1016\/j.ejmech.2026.119353_bib33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.xphs.2016.12.002","article-title":"Optimizing oral bioavailability in drug discovery: an overview of design and testing strategies and formulation options","volume":"106","author":"Aungst","year":"2017","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.119353_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107373","article-title":"Synthesis and biological evaluation of halogen-substituted novel \u03b1-Ketoamides as potential protein aggregation modulators in Alzheimer's disease","author":"Das","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119353_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nsmb.2971","article-title":"A molecular chaperone breaks the catalytic cycle that generates toxic A\u03b2 oligomers","volume":"22","author":"Cohen","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.119353_bib36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4162\/nrp.2015.9.5.480","article-title":"Protective role of caffeic acid in an A\u03b225-35-induced alzheimer's disease model","volume":"9","author":"Kim","year":"2015","journal-title":"Nutr. Res. Prac."},{"key":"10.1016\/j.ejmech.2026.119353_bib37","article-title":"Human IgLON5 antibodies reduce neuronal IgLON5 clusters and cause motor dysfunction in mice","volume":"13","author":"Serafim","year":"2026","journal-title":"Neurology: Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2026.119353_bib38","series-title":"Chemical Proteomics: Methods and Protocols","first-page":"265","article-title":"Working with small molecules: preparing and storing stock solutions and determination of kinetic solubility","author":"Wolf","year":"2011"},{"key":"10.1016\/j.ejmech.2026.119353_bib39","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1039\/C8MD00196K","article-title":"Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A","volume":"9","author":"Nath","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2026.119353_bib40","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1055\/s-0043-110052","article-title":"Prediction of permeation and cellular transport of Silybum marianum extract formulated in a nanoemulsion by using PAMPA and Caco-2 cell models","volume":"83","author":"Piazzini","year":"2017","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2026.119353_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10822-026-00767-9","article-title":"Xanthine oxidase inhibitory potential of flavonoids from pistacia integerrima: insights from molecular docking, MD simulations, SwissADME ADMET analysis and StopTox toxicity profile evaluation","volume":"40","author":"Rauf","year":"2026","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2026.119353_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.31643\/2023\/6445.13","article-title":"SwissADME and pkCSM webservers predictors: an integrated online platform for accurate and comprehensive predictions for in silico ADME\/T properties of artemisinin and its derivatives","volume":"325","author":"Azzam","year":"2023","journal-title":"Kompleksnoe Ispolzovanie Mineralnogo Syra= Complex use of mineral resources"},{"key":"10.1016\/j.ejmech.2026.119353_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13321-021-00522-2","article-title":"Gnina 1.0: molecular docking with deep learning","volume":"13","author":"McNutt","year":"2021","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2026.119353_bib44","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.3390\/molecules26237369","article-title":"Virtual screening with Gnina 1.0","volume":"26","author":"Sunseri","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119353_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107532","article-title":"Evaluation of consensus scoring methods for AutoDock Vina, smina and idock","volume":"96","author":"Masters","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2026.119353_bib46","doi-asserted-by":"crossref","DOI":"10.1063\/5.0012280","article-title":"CHARMM-GUI supports the amber force fields","volume":"153","author":"Lee","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2026.119353_bib47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/acschemneuro.2c00738","article-title":"Mechanistic insight into the inhibition of choline acetyltransferase by proton pump inhibitors","volume":"14","author":"Baidya","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119353_bib48","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s11030-023-10645-3","article-title":"Artificial intelligence assisted identification of potential tau aggregation inhibitors: ligand-and structure-based virtual screening, in silico ADME, and molecular dynamics study","volume":"28","author":"Das","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2026.119353_bib49","article-title":"Synthesis, in silico study and biological evaluation of N\u2010(Benzothiazol\/Thiazol\u20102\u2010yl) benzamide derivatives as quorum sensing inhibitors against Pseudomonas aeruginosa","volume":"20","author":"Sharma","year":"2023","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2026.119353_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/prot.26417","article-title":"N\u2010glycosylation induced changes in tau protein dynamics reveal its role in tau misfolding and aggregation: a microsecond long molecular dynamics study","volume":"91","author":"Mathew","year":"2023","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.ejmech.2026.119353_bib51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1021\/acs.jctc.2c01023","article-title":"Projected hybrid density functionals: method and application to core electron ionization","volume":"19","author":"Janesko","year":"2023","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2026.119353_bib52","series-title":"Gaussian 16","author":"Frisch","year":"2016"},{"key":"10.1016\/j.ejmech.2026.119353_bib53","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1080\/07391102.2022.2025906","article-title":"Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1, 3, 4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors","volume":"41","author":"Acar \u00c7evik","year":"2023","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:27:40Z","timestamp":1792643260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":53,"alternative-id":["S0223523426007981"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119353","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design, synthesis, and biological evaluation of indole\u2013piperazine based \u03b1-ketoamide derivatives as dual A\u03b2 and tau aggregation modulators for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119353"}}